BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4186563)

  • 1. [Clinical, respiratory functional, bacteriological and immunological observations on the use of Bisolvon].
    Bernardini V; Camerota G; Baronti A; Curti PC
    Minerva Med; 1969 Sep; 60(75):3514-20. PubMed ID: 4186563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bisolvon in pneumological practice].
    Ollagnier C; Vallon MC
    Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies].
    Baracco F; Repetto E; Giordano L
    Minerva Med; 1969 Sep; 60(75):3509-13. PubMed ID: 5344811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bisolvon in the treatment of the tracheo-bronchial secretory syndrome of the laryngectomized].
    Ameli M
    Minerva Med; 1969 Sep; 60(75):3503-8. PubMed ID: 5344810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on expectoration, respiratory function, hepatic and cardiac function of subjects with chronic bronchopneumopathies].
    Scarpa GL; Malavasi A; Dimich D; Giraudi D
    Minerva Med; 1969 Sep; 60(76):3594-9. PubMed ID: 5823756
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Ercillo L; Mollica G
    Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical considerations on a recent preparation with bronchial secretolytic action].
    Santilli E; Castellana G
    Minerva Med; 1969 Sep; 60(76):3583-93. PubMed ID: 5823755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings].
    Lenzini L; Barnabè R
    Minerva Med; 1969 Sep; 60(76):3580-2. PubMed ID: 5823754
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of a new substance with secretolytic action].
    BontĂ  L
    Minerva Med; 1969 Sep; 60(75):3525-44. PubMed ID: 5344813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged automatic respiration and bronchial obstruction. Experience with a new "expectorant" in a Resuscitation Department].
    De Medici M; Del Vecchio PE
    Minerva Med; 1969 Sep; 60(76):3571-4. PubMed ID: 5823752
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apropos of 27 patients treated with bisolvomycin].
    Breuil K
    Bord Med; 1971 Sep; 4(9):2469-70. PubMed ID: 5123583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Brignani F; Cavalli A; Fabbri M; Melica A
    Minerva Med; 1969 Sep; 60(75):3545-8. PubMed ID: 5344814
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with a new secretolytic drug.
    Villa R; Orlandini GC
    Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract]   [Full Text] [Related]  

  • 14. [Respiratory complications after abdominal surgery: therapeutic and diagnostic value of bronchodilator-secretolytic-expectorant preoperative treatment].
    Capria V; Quacquarelli O
    Minerva Med; 1969 Sep; 60(75):3549-56. PubMed ID: 5344815
    [No Abstract]   [Full Text] [Related]  

  • 15. [Our clinical experience with a new antitussive secretolytic drug].
    Cuocolo R; Jovino R; Tufano R; Triggiani E
    Minerva Med; 1969 Sep; 60(76):3565-70. PubMed ID: 5823751
    [No Abstract]   [Full Text] [Related]  

  • 16. [A derivative of benzyl-amine in the therapy of respiratory diseases in children].
    Gambi R; Ongaro F; Paoli R; Russo U
    Minerva Med; 1969 Sep; 60(76):3575-9. PubMed ID: 5823753
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies].
    Carnimeo N; Fino E; Maiorano V; Marzullo F
    Minerva Med; 1969 Sep; 60(76):3557-64. PubMed ID: 5823750
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Trombini V
    Minerva Med; 1969 Sep; 60(76):3600-3. PubMed ID: 5823757
    [No Abstract]   [Full Text] [Related]  

  • 19. [The parenteral use of a derivative of benzylamine in the control of tracheobronchial patological secretions].
    Bianchetti L; Chiri A
    Minerva Med; 1969 Sep; 60(75):3521-4. PubMed ID: 5344812
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical trial of bromhexine.
    Thompson KJ; Reeve J
    N Z Med J; 1972 Aug; 76(483):73-6. PubMed ID: 4264310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.